JPRN-UMIN000023527已完成未知
A exploratory phase II study of SOX followed by interval S-1 alone therapy for advanced gastric cancer: Stop and Go study - SOX followed by interval S-1 alone therapy for advanced gastric cancer
Department of Surgery, Gastroenterological Center, Medical Center, Yokohama City University0 个研究点目标入组 24 人开始时间: 2016年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Drug allergy 2. Peripheral neurodisturvance 3. GI tract bleeding 4. Continuation of phenitoin, warfain 5. Uncontrollable infection 6. Interstitial pneumonia 7. Other cancers 8. DPD deficiency 9. Family planning 10. Inappropriate patients
研究者
相似试验
招募中
1 期
Safety and efficacy of SOX after chemoradiation therapyJPRN-jRCTs061210016Fujiwara Yoshiyuki12
已完成
不适用
The randomized phaseII study of SOX and SIR sequential therapy as TS-1 based regimens in Advanced Colorectal Cancer; WSTAR trialcolorectal cancerJPRN-UMIN000007697Chiba surgical oncology development association130
已完成
2 期
A randomized Phase II study comparing SOX+B-mab with SOX+C-mab in patients with previously untreated recurrent advanced colorectal cancer with KRAS wild type.previously untreated recurrent advanced colorectal cancer with KRAS wild typeJPRN-UMIN000006706Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment Group50
已完成
2 期
Randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer.(WJOG8315G)advanced gastric cancer.JPRN-UMIN000020864West Japan Oncology Group160
进行中（未招募）
2 期
Randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer.(WJOG8315G)Advanced gastric cancer.JPRN-jRCTs041190004Makiyama Akitaka160